These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer. Cieśla M; Ngoc PCT; Cordero E; Martinez ÁS; Morsing M; Muthukumar S; Beneventi G; Madej M; Munita R; Jönsson T; Lövgren K; Ebbesson A; Nodin B; Hedenfalk I; Jirström K; Vallon-Christersson J; Honeth G; Staaf J; Incarnato D; Pietras K; Bosch A; Bellodi C Mol Cell; 2021 Apr; 81(7):1453-1468.e12. PubMed ID: 33662273 [TBL] [Abstract][Full Text] [Related]
4. The spliceosome is a therapeutic vulnerability in MYC-driven cancer. Hsu TY; Simon LM; Neill NJ; Marcotte R; Sayad A; Bland CS; Echeverria GV; Sun T; Kurley SJ; Tyagi S; Karlin KL; Dominguez-Vidaña R; Hartman JD; Renwick A; Scorsone K; Bernardi RJ; Skinner SO; Jain A; Orellana M; Lagisetti C; Golding I; Jung SY; Neilson JR; Zhang XH; Cooper TA; Webb TR; Neel BG; Shaw CA; Westbrook TF Nature; 2015 Sep; 525(7569):384-8. PubMed ID: 26331541 [TBL] [Abstract][Full Text] [Related]
5. Non-canonical functions of spliceosome components in cancer progression. Ivanova OM; Anufrieva KS; Kazakova AN; Malyants IK; Shnaider PV; Lukina MM; Shender VO Cell Death Dis; 2023 Feb; 14(2):77. PubMed ID: 36732501 [TBL] [Abstract][Full Text] [Related]
6. Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities. Blijlevens M; Li J; van Beusechem VW Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065983 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic Targeting of RNA Splicing in Cancer. Bonner EA; Lee SC Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510283 [TBL] [Abstract][Full Text] [Related]
8. Emerging roles of spliceosome in cancer and immunity. Yang H; Beutler B; Zhang D Protein Cell; 2022 Aug; 13(8):559-579. PubMed ID: 34196950 [TBL] [Abstract][Full Text] [Related]
9. RNA splicing, cell signaling, and response to therapies. Abou Faycal C; Gazzeri S; Eymin B Curr Opin Oncol; 2016 Jan; 28(1):58-64. PubMed ID: 26575690 [TBL] [Abstract][Full Text] [Related]
10. Signature microRNAs of nuclear Sm complex associated with breast cancer tumorigenesis. Zhang X; Shen B; Cui Y J Cell Biochem; 2018 Jul; 119(7):5426-5436. PubMed ID: 29363793 [TBL] [Abstract][Full Text] [Related]
11. Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing. López-Cánovas JL; Hermán-Sánchez N; Moreno-Montilla MT; Del Rio-Moreno M; Alors-Perez E; Sánchez-Frias ME; Amado V; Ciria R; Briceño J; de la Mata M; Castaño JP; Rodriguez-Perálvarez M; Luque RM; Gahete MD Clin Transl Med; 2022 Nov; 12(11):e1102. PubMed ID: 36419260 [TBL] [Abstract][Full Text] [Related]
12. Distinct Minor Splicing Patterns across Cancers. Levesque L; Salazar N; Roy SW Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205431 [TBL] [Abstract][Full Text] [Related]
13. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Makishima H; Visconte V; Sakaguchi H; Jankowska AM; Abu Kar S; Jerez A; Przychodzen B; Bupathi M; Guinta K; Afable MG; Sekeres MA; Padgett RA; Tiu RV; Maciejewski JP Blood; 2012 Apr; 119(14):3203-10. PubMed ID: 22323480 [TBL] [Abstract][Full Text] [Related]
14. Mechanistic insights into precursor messenger RNA splicing by the spliceosome. Shi Y Nat Rev Mol Cell Biol; 2017 Nov; 18(11):655-670. PubMed ID: 28951565 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer. Piqué L; Martinez de Paz A; Piñeyro D; Martínez-Cardús A; Castro de Moura M; Llinàs-Arias P; Setien F; Gomez-Miragaya J; Gonzalez-Suarez E; Sigurdsson S; Jonasson JG; Villanueva A; Vidal A; Davalos V; Esteller M Oncogene; 2019 Nov; 38(45):7106-7112. PubMed ID: 31409895 [TBL] [Abstract][Full Text] [Related]
16. The spliceosome: a self-organized macromolecular machine in the nucleus? Rino J; Carmo-Fonseca M Trends Cell Biol; 2009 Aug; 19(8):375-84. PubMed ID: 19616950 [TBL] [Abstract][Full Text] [Related]
17. Variant snRNPs: New players within the spliceosome system. Vazquez-Arango P; O'Reilly D RNA Biol; 2018 Jan; 15(1):17-25. PubMed ID: 28876172 [TBL] [Abstract][Full Text] [Related]
18. Identification of spliceosome components pivotal to breast cancer survival. An J; Luo Z; An W; Cao D; Ma J; Liu Z RNA Biol; 2021 Jun; 18(6):833-842. PubMed ID: 32965163 [TBL] [Abstract][Full Text] [Related]
19. New connections between splicing and human disease. Padgett RA Trends Genet; 2012 Apr; 28(4):147-54. PubMed ID: 22397991 [TBL] [Abstract][Full Text] [Related]
20. Targeting the spliceosome machinery: A new therapeutic axis in cancer? Eymin B Biochem Pharmacol; 2021 Jul; 189():114039. PubMed ID: 32417188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]